Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Mantle cell lymphoma recurrent
ADR ID BADD_A07395
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.05      Mantle cell lymphomas
01.15.05.002      Mantle cell lymphoma recurrent
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.05      Mantle cell lymphomas
16.28.05.002      Mantle cell lymphoma recurrent
Description Not Available
MedDRA Code 10026800
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Centrocytic (mantle cell) lymphoma (Kiel classification) recurrent | Mantle cell lymphoma recurrent | Mantle zone lymphoma recurrent | Small cleaved cell diffuse or nodular rarely diffuse mixed or large cleaved cell recurrent | Small cleaved follicular cell lymphoma (Mantle cell lymphoma) recurrent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01119Ibrutinib0.000951%
BADD_D01253Lenalidomide0.001591%
BADD_D02345Venetoclax0.000112%
The 1th Page    1    Total 1 Pages